D1 receptor agonist improves sleep–wake parameters in experimental parkinsonism
- 1 March 2014
- journal article
- Published by Elsevier in Neurobiology of Disease
- Vol. 63, 20-24
Abstract
No abstract availableKeywords
Funding Information
- French Association of Willis Ekbom disease (AFE)
This publication has 28 references indexed in Scilit:
- Study of the antidyskinetic effect of eltoprazine in animal models of levodopa‐induced dyskinesiaMovement Disorders, 2013
- Dopamine Transporter Binding Is Unaffected by L-DOPA Administration in Normal and MPTP-Treated MonkeysPLOS ONE, 2010
- Dopaminergic Regulation of Sleep and Cataplexy in a Murine Model of NarcolepsySLEEP, 2010
- Sleep disorders in Parkinson's disease: The contribution of the MPTP non-human primate modelExperimental Neurology, 2009
- Pharmacological Analysis Demonstrates Dramatic Alteration of D1Dopamine Receptor Neuronal Distribution in the Rat Analog of l-DOPA-Induced DyskinesiaJournal of Neuroscience, 2009
- A nationwide survey of excessive daytime sleepiness in Parkinson's disease in FranceMovement Disorders, 2007
- Dopaminergic Control of Sleep–Wake StatesJournal of Neuroscience, 2006
- Increased D1 dopamine receptor signaling in levodopa‐induced dyskinesiaAnnals of Neurology, 2004
- Relationship between the Appearance of Symptoms and the Level of Nigrostriatal Degeneration in a Progressive 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Macaque Model of Parkinson's DiseaseThe Journal of Neuroscience, 2001
- A chronic MPTP model reproducing the slow evolution of Parkinson's disease: evolution of motor symptoms in the monkeyBrain Research, 1997